Samantha Bucktrout

Samantha Bucktrout currently serves as the Head of Research at Grey Wolf Therapeutics, beginning in October 2024. Prior to this, Samantha held prominent roles at Akamis Bio, where the positions included Senior Vice President and Vice President of Research Strategy. At the Parker Institute for Cancer Immunotherapy, from October 2017 to May 2022, Samantha led initiatives in brain tumor research and co-developed novel therapeutics. Earlier experience includes leadership roles at Pfizer in immunology research and multiple academic positions focusing on dendritic cells and autoimmune conditions. Samantha holds a Ph.D. and a Research Doctorate in Immunology from The University of Edinburgh, as well as a Bachelor of Science degree from the University of Aberdeen.